Velcade is a medication that has Bortezomibe as its active ingredient.
This medication is an injectable antineoplastic agent, used to treat tumors such as multiple myeloma.
Its action is to interrupt the cell's balancing mechanism, resulting in delayed tumor growth.
Velcade indications
Treatment of Multiple Myeloma.
Side Effects of Velcade
Weakness; Headache; insomnia; dizziness; anxiety; diarrhea; hunger decrease; constipation; lack of appetite; vomiting; indigestion; decreased blood platelets; anemia; swelling; Low pressure; joint pain; limb pain; bone pain; muscle pain; back pain; difficulty in breathing; cough, pneumonia; rash on the skin; itch; dehydration; blurred vision.
Contraindications for Velcade
Pregnancy risk D; lactating women; hypersensitivity to the product; children under 18 years.
How to Use Velcade
Injectable Use
Adults
- Treatment for 21 days: Inject 1.3 mg of Velcade intravenously, twice a week, for 2 weeks (on days 1, 4, 8 and 11). The procedure must be followed by a 10-day rest. Treatment for 35 days: Inject 1.3 mg of Velcade intravenously, once a week, for 4 weeks (on days 1, 8, 15 and 22). The procedure must be followed by a 13-day rest.
Attention: Doses should be administered within a minimum of 72 hours between them.
